No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Industrial - Machinery
Established in 1922 and headquartered in Zug, Switzerland, Medmix AG stands as a global leader in innovating, manufacturing, and distributing high-precision devices and services. These solutions are meticulously engineered for the controlled mixing, application, and injection of liquids across various viscosities, serving diverse healthcare, consumer, and industrial markets worldwide. The company operates through five key divisions: Dental, Drug Delivery, Surgery, Industry, and Beauty. The Dental segment offers essential tools such as mixing tips, dispensers, needles, and accessories, alongside support services for applications including prosthetics, restorative procedures, anesthesiology, and cosmetic dentistry. In its Drug Delivery segment, Medmix develops critical devices for administering medications like fertility drugs, growth hormones, and treatments for specific diabetes conditions, osteoporosis, and rare diseases. The Surgery segment provides specialized mixing and delivery systems utilized for injecting bone cement and applying hemostatic sealants to manage both internal and external wounds during surgical interventions. For industrial clients, the Industry division produces robust dispensers, cartridges, and mixers for two-component adhesives and sealants, indispensable in sectors such as construction, transportation, electronics, infrastructure, and broader manufacturing. Lastly, the Beauty segment supplies micro brushes, mascara applicators, lip gloss, and concealers. Medmix AG markets its comprehensive product range under well-recognized brands, including Mixpac, Transcodent, Cox, MK, Medmix, Haselmeier, and Geka.
www.medmix.swissNo one on the platform currently holds MEDX.SW.
No tracked institution reports a position in MEDX.SW as of their last filing.
No one on the platform has traded MEDX.SW yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 3.2% | — | — | — | ||
| Rev. Growth % | -7.4% | 5.0% | ||||
| Profit Margin % | 1.4% | 2.4% | ||||
| Free Cash Flow Margin % | 7.4% | 6.0% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $443M | -2.2% | $0.52 | $0.40–$0.60 | — | 3 |
| 2027 | $467M | +5.3% | $0.64 | $0.32–$0.89 | — | 3 |
| 2028 | $490M | +4.9% | $0.76 | $0.39–$0.98 | — | 3 |
| 2029 | $526M | +7.3% | $1.07 | $1.05–$1.09 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-24 | $0.35 | $0.01 | -96.5% |
| 2026-02-26 | $0.33 | $0.33 | +0.0% |
| 2025-07-23 | $0.40 | $0.39 | -2.5% |
| 2025-02-26 | $0.39 | $-0.31 | -179.2% |
| 2024-07-18 | $0.40 | $0.39 | -2.5% |
| 2024-02-22 | $0.39 | $0.39 | +0.0% |
| 2023-07-20 | $0.51 | $0.18 | -65.0% |
| 2023-02-22 | $0.49 |
| $0.49 |
| +0.0% |
| $387M |
| — |
| MIKN.SWMikron Holding AG | $15.85 | -3.35% | $264M | — |
| MTG.SWMeier Tobler Group AG | $33.80 | -0.73% | $365M | — |
Source: Financial Modeling Prep · peers by sector/industry